I agree that this site is using cookies. You can find further informations here.
X
Paccone, A
127  results:
Search for persons X
?
1

SODIUM–GLUCOSE COTRANSPORTER 2 INHIBITOR DAPAGLIFLOZIN REDU..:

Quagliariello, V ; Bisceglia, I ; Iovine, M...
European Heart Journal Supplements.  26 (2024)  Supplement_2 - p. ii119-ii119 , 2024
Link: https://doi.org/10.1093/..
 
?
2

Sodium-glucose cotransporter 2 inhibitor dapagliflozin prev..:

Quagliariello, V. ; Canale, M. L. ; Bisceglia, I....
Frontiers in Cardiovascular Medicine.  11 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
3

SOLUBLE GUANYLATE CYCLASE ACTIVATOR VERICIGUAT PREVENTS ANT..:

Quagliariello, V ; Iovine, M ; Giacobbe, I...
European Heart Journal Supplements.  26 (2024)  Supplement_2 - p. ii31-ii31 , 2024
Link: https://doi.org/10.1093/..
 
?
4

Combinatorial immune checkpoint blockade increases myocardi..:

Quagliariello, V. ; Passariello, M. ; Bisceglia, I....
Frontiers in Cardiovascular Medicine.  11 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
5

P424 MEDIASTINAL ROUND CELL SARCOMA WITH PULMONARY ARTERY S..:

Canale, M ; Bisceglia, I ; Gallucci, G...
European Heart Journal Supplements.  25 (2023)  Supplement_D - p. D212-D212 , 2023
Link: https://doi.org/10.1093/..
 
?
6

P128 CTLA–4 AND PD–1 BLOCKING AGENTS AFFECTS LONGITUDINAL A..:

Quagliariello, V ; De Lorenzo, C ; Passariello, M...
European Heart Journal Supplements.  25 (2023)  Supplement_D - p. D89-D89 , 2023
Link: https://doi.org/10.1093/..
 
?
7

P383 DAPAGLIFLOZIN REDUCES SYSTEMIC PCSK9 LEVELS IN PRECLIN..:

Quagliariello, V ; Palma, G ; Luciano, A...
European Heart Journal Supplements.  25 (2023)  Supplement_D - p. D195-D195 , 2023
Link: https://doi.org/10.1093/..
 
?
8

C7 COMBINATION OF SPIRULINA, GANODERMA LUCIDUM AND MORINGA ..:

Quagliariello, V ; Ostacolo, C ; De Anseris, R...
European Heart Journal Supplements.  25 (2023)  Supplement_D - p. D3-D3 , 2023
Link: https://doi.org/10.1093/..
 
?
9

P470 BERBERINE ASSOCIATED TO DAPAGLIFLOZIN EXERTS SYNERGIST..:

Quagliariello, V ; Scherillo, M ; Maurea, F...
European Heart Journal Supplements.  25 (2023)  Supplement_D - p. D227-D227 , 2023
Link: https://doi.org/10.1093/..
 
?
10

C12 DAPAGLIFLOZIN INCREASES PAMPK AND REDUCES MYOCARDIAL AN..:

Quagliariello, V ; Paccone, A ; Iovine, M...
European Heart Journal Supplements.  25 (2023)  Supplement_D - p. D5-D5 , 2023
Link: https://doi.org/10.1093/..
 
?
11

Anti CTLA-4 and PD-1 monoclonal antibodies increases system..:

Maurea, N ; De Lorenzo, C ; Passariello, M...
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
12

P420 A CANCER PATIENT WITH PULMONARY THROMBOEMBOLISM: IS IT..:

Russo, G ; Guglielmi, A ; Cherubini, A...
European Heart Journal Supplements.  25 (2023)  Supplement_D - p. D210-D210 , 2023
Link: https://doi.org/10.1093/..
 
?
13

C31 NEXT GENERATION MYOCARDITIS:

Mistrulli, R ; Cartoni, D ; Andreoli, F...
European Heart Journal Supplements.  25 (2023)  Supplement_D - p. D13-D14 , 2023
Link: https://doi.org/10.1093/..
 
?
14

SGLT2 i Dapagliflozin reduces NF-kB expression in heart and..:

Maurea, N ; Bisceglia, I ; Iovine, M...
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
15

CTLA-4 and PD-1 blocking agents affects longitudinal and ra..:

Maurea, N ; De Lorenzo, C ; Passariello, M...
European Heart Journal - Cardiovascular Imaging.  24 (2023)  Supplement_1 - p. , 2023
Link: https://doi.org/10.1093/..
 
1-15